SELL (40-50% trim now, hard stop at 1,200, no new capital in 1,200-1,290 zone)

• Stock ran from ~712 to 1,292 (81% vertical move); 80%+ moves in mega-cap names typically mean-revert 20-40% from the peak
• Aggressive analyst's own Q3 analysis showed a 30% drawdown scenario—math demands more than 25% position reduction
• Trailing stops at 50 SMA (1,182) means giving back 4.4% before exiting; on 1.1 trillion dollar name, that's substantial dollar loss
• Stock is 17% above 200 SMA (at 1,053); distance from 200 SMA is a mean-reversion gauge, not a bullish signal—top decile stretch
• Balance sheet shifted from 39 billion to 47.86 billion in long-term debt in a single quarter (8.86 billion issuance)
• Supportive macro backdrop does not override confirmed divergences and failed breakout at 1,292
• At 1.1 trillion valuation, growth needs to 'grow into' it rather than above it; multiple expansion is not infinite
• Company-specific drawdowns in high-multiple names are typically sharper and longer than macro-driven drawdowns
• Recommend trimming 40-50% NOW in 1,230-1,250 zone rather than waiting for 1,280-1,300; in failed breakouts, price retests from below
• Hard stop at 1,200 on closing basis (not 50 SMA trailing stop) for remaining position—no discretion, no narrative override
• No new capital until: (1) confirmed close above 1,292 with volume >5M shares and MACD histogram expansion, OR (2) pullback to 1,100-1,180 with RSI below 40 and MACD turning
• 1,200-1,290 zone is a no-fly zone for new capital given valuation stretch and technical warning signs

→ vs aggressive: 25-30% trim is 'cosmetic risk management'—leaving 70-75% of position exposed to one-to-three downside if 1,200 level breaks is not meaningful risk reduction

→ vs aggressive: Calling a 25-30% trim 'harvesting gains' while 75% remains exposed to multiple risk is congratulating ourselves on protection we didn't actually deliver

→ vs aggressive: Q3 analysis showing 30% drawdown scenario was the analyst's own math—holding 70% through that scenario contradicts their own risk framework

→ vs aggressive: Stock went from 712 to 1,292 (81% move); 80%+ vertical moves in mega-cap names don't consolidate politely—they mean-revert 20-40% from peak

→ vs neutral: HOLD recommendation is 'the most dangerous position on the table'—trailing stops at 1,182 give back 4.4% before exiting, which multiplies to substantial dollar loss on large position

→ vs neutral: Trailing stops become 'trailing hope zones' in real drawdowns—price hits stop, fundamentals are great, narrative is compelling, execution fails, position bleeds 15%

→ vs neutral: 200 SMA distance being framed as confirmation of intact medium/long-term bias is backwards—17% above 200 SMA is a stretched signal and mean-reversion gauge, not bullish confirmation

→ vs neutral: 86% probability of no Fed cuts and 8% recession probability doesn't override a failed breakout with confirmed divergences; supportive backdrop and rising price are not the same thing

→ vs aggressive: Both analysts underemphasized the balance sheet shift from 39B to 47.86B LT debt (8.86B issuance in one quarter); management capital allocation signals the easy compounding phase is behind and execution phase has begun

→ vs neutral: Calling fundamentals 'best in class' while ignoring that 8.86B debt issuance means growth requires external financing rather than organic FCF (despite 11B TTM FCF being strong)

HOLD

• Recommends 33-40% trim size, splitting the difference between the aggressive analyst's 25-30% and conservative analyst's 40-50%
• Execution in tranches across current zone and any $1,260 to $1,280 retest rather than waiting for $1,290
• First warning stop at closing print below $1,200 on the 20 SMA (20 SMA at $1,200.21) with additional 20-25% trim of remaining position
• Hard exit stop at closing print below $1,182 on the 50 SMA (50 SMA at $1,182)
• Re-entry trigger at $1,200 to $1,220 with RSI reset below 45 and MACD histogram turning positive, OR breakout above $1,292 with volume confirmation
• Recommends protective puts on remaining ~60-67% position through next earnings window given ATR of $40 and binary catalysts
• Challenges both analysts on hedging: neither addressed protective options despite $40 ATR and upcoming Q3 earnings and retatrutide phase 3 catalysts
• Supports trim despite acknowledging 50 SMA rising, 200 SMA rising, and price above all major averages
• Critiques conservative analyst's 20-40% mean reversion framework as inapplicable to accelerating fundamentals (Q2 revenue grew 47.7% YoY)

→ vs aggressive: Called the chart setup a 'textbook distribution pattern' with near-certainty, which is too confident given the underlying trend structure still being intact with rising 50 SMA, rising 200 SMA, and price above all major averages

→ vs aggressive: Math doesn't support the stated conviction: if downside is 27% (stock to $900 on 30% growth instead of 47%) but only 25% trimmed, that leaves 70% exposed to the exact scenario cited as the risk

→ vs conservative: Hard stop at $1,200 on closing basis is at the exact 20 SMA level ($1,200.21) that price is statistically likely to test and bounce from in any healthy consolidation, conflating a stop with an entry trigger

→ vs conservative: Generic 20-40% mean reversion rule applies to stocks whose fundamentals have stalled, but LLY's fundamentals accelerated with Q2 revenue up 47.7% YoY and operating margin expanded 900 basis points in four quarters

→ vs conservative: No-fly zone of $1,200 to $1,290 is the entire current trading range, declaring the entire zone off-limits is avoidance not risk management

→ vs conservative: Re-entry zone of $1,100 to $1,180 is too deep; doesn't need to wait for 10% pullback when the earnings story is still accelerating